Noticias de REGN_US
Noticias del mercado
Últimas noticias sobre REGN_US — 308 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Regeneron Presses Amgen for Eylea Antitrust Damages Evidence
Royal Bank Of Canada Issues Pessimistic Forecast for Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price
REGN Maintained by Barclays -- Price Target Lowered to $917
Regeneron Pharmaceuticals (NASDAQ:REGN) Given New $917.00 Price Target at Barclays
Leerink Partners Adjusts Regeneron Pharmaceuticals Price Target to $792 From $873
Barclays Adjusts Regeneron Pharmaceuticals Price Target to $917 From $923
Wells Fargo Adjusts Regeneron Pharmaceuticals PT to $800 From $825
Bernstein Adjusts Regeneron Pharmaceuticals PT to $916 From $913
Truist Financial Lowers Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $796.00
REGN Maintains by Truist Securities -- Price Target Lowered to $796
Regeneron Pharmaceuticals (NASDAQ:REGN) Given New $800.00 Price Target at Wells Fargo & Company
RBC Trims Price Target on Regeneron Pharmaceuticals to $762 From $779, Keeps Sector Perform Rating
REGN Maintained by Wells Fargo -- Price Target Lowered to $800
MSN Money
Regeneron Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors
REGN SWOT Analysis: Financial Strength and Growth Opportunities Revealed in 10-Q Filing
Página 4 de 16
